IVISBRITE D-LUCIFERIN POTASSIUM-Revvity
Order
Cat.NO Name Size
122799 IVISBRITE D-LUCIFERIN POTASSIUM 1g

 

  • Product overview
  • Brand introduction
  • Q&A
  • Data download

Luciferin is a chemical substance found in the cells of various bioluminescent organisms. When Luciferin is oxidized under the catalytic effects of luciferase and ATP, light is produced. Because the reaction is dependent on ATP, it allows researchers to determine the presence of energy or life. Firefly luciferin is a particularly good reporter for in vitro imaging due to properties of its emission spectra.

 

Luciferin can be used in a number of ways. It can be used in a variety of in vitro assays, where the production of light can be monitored with either a luminometer or a scintillation counter. It can also be used to monitor light production in vivo, and can be monitored with Revvity's IVIS® imaging platform. Because luciferin can penetrate cell membranes, it allows transformed cells to be monitored for luciferase activity.

 

Luciferin can also be used with Revvity's IVISbrite luciferase expressing tumor cell lines and our IVISbrite lentiviral particles. There are many considerations when choosing a luciferin substrate and it is important to know that you are using the highest quality Luciferin for your experiments.

 

This IVISbrite D-Luciferin Potassium Salt Bioluminescent Substrate is available in a 1g unit size.

Molecular Information: C11H7 KN2 O3 S2 (MW: 318.4)

 

Product features

Specifications

 

 

At Revvity, we regard "impossibility" as inspiration and "inability" as the driving force. Revvity offers health science solutions, cutting - edge technologies and professional services, with its business covering the entire end - to - end process of scientific research exploration, development, diagnosis, and treatment. Relying on years of in - depth cultivation in fields such as translational multi - omics technology, biomarker identification, imaging, disease prediction, screening, detection and diagnosis, and informatics, Revvity is using the power of technology to break through the boundaries of human potential.

 

In 2023, Revvity's turnover exceeded $2.7 billion. It has more than 11,000 employees worldwide and provides diverse services for customers such as pharmaceutical and biotechnology enterprises, diagnostic laboratories, scientific research institutions and government agencies. The company is a member of the S&P 500 Index, and its customers are spread across more than 190 countries and regions around the world.

×